EVAR术后2年影像随访可预测长期结局
本研究纳入282例接受Zenith支架EVAR的AAA患者,按2年时有无内漏及瘤囊是否缩小≥5 mm分为两组,随访至2019年底。结果显示2年时无内漏且瘤囊缩小≥5 mm的患者长期再干预率和破裂率显著更低,提示此类患者2年后可安全个体化延长随访间隔。
要点
- 2年时无内漏且瘤囊缩小≥5 mm者12年免于再干预率95%,显著高于对照组的31%。
- 2年时无内漏且瘤囊缩小≥5 mm者12年免于破裂率100%,显著高于对照组的91%。
- 该分类预测长期需再干预并发症的敏感度89%、特异度74%,支持个体化延长随访。
核心结论
- 2年时无内漏且瘤囊缩小≥5 mm的患者长期再干预和破裂显著更少,2年后随访间隔可个体化安全延长。
研究设计与样本
- 2000至2010年282例择期EVAR的AAA患者,均使用Zenith支架,每年随访至2019年底。
- 按2年时有无内漏及瘤囊是否缩小≥5 mm分为A组(无内漏且缩小≥5 mm,n=137,63%)和B组(任何内漏和/或缩小<5 mm,n=82,37%)。
主要发现
- 平均随访83个月(范围0-229个月),2年总生存率84%(n=237),A、B两组总生存无显著差异(P=.73)。
- 12年免于AAA破裂率A组100%、B组91%,差异显著(P=.002)。
- 12年免于再干预率A组95%、B组31%,差异显著(P<.001)。
- 该分类预测长期随访中需再干预并发症的敏感度89%、特异度74%。
关键数值与推荐
- A组定义为无内漏且瘤囊缩小≥5 mm(n=137,63%),B组为任何内漏和/或瘤囊缩小<5 mm(n=82,37%)。
临床怎么用
- 对2年时无内漏且瘤囊缩小≥5 mm的Zenith支架EVAR患者,可考虑个体化延长随访间隔。
局限性
- 研究仅纳入使用Zenith支架的患者,结论外推至其他支架需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Lifelong imaging follow-up remains the reference standard after endovascular aneurysm repair (EVAR). Because the number of EVARs has been increasing, an individually optimized follow-up protocol is desirable. The aim of the present study was to investigate the possibility of creating such a protocol by evaluating patients' follow-up images and to compare the findings with their freedom from reintervention and abdominal aortic aneurysm (AAA) rupture. METHODS: From 2000 to 2010, 282 patients with an AAA had undergone elective EVAR with the Zenith stent-graft. The patients were followed up annually until the end of 2019. The patients were categorized into two groups according to the presence of any endoleak or sac shrinkage at 2 years. Group A included those with no detectable endoleak plus aneurysm sac shrinkage of ≥5 mm (n = 137; 63%), and group B included those with any type of endoleak and/or no significant aneurysm sac shrinkage (<5 mm; n = 82; 37%). RESULTS: The mean follow-up was 83 months (range, 0-229 months), and the overall survival at 2 years was 84% (n = 237). No significant difference was found in overall survival between groups A and B (P = .73). However, a significant difference was found in freedom from AAA rupture at 12 years, favoring group A (group A, 100%; group B, 91%; P = .002). Furthermore, in group A, the freedom from reintervention was 95% at 12 years compared with only 31% in group B (P < .001). The sensitivity of the categorization was 89% and the specificity was 74% for the finding of a complication requiring a reintervention during long-term follow-up. CONCLUSIONS: Patients without an endoleak and a reduction of ≥5 mm in aneurysm size at 2 years had significantly fewer late reinterventions and ruptures during long-term follow-up compared with their counterparts using the Zenith stent-graft (Cook Medical, Bloomington, Ind). This finding suggests that, for these patients, the follow-up interval can be personalized and safely extended after 2 years.
引用
- Väärämäki S, Uurto I, Suominen V, et al. Postoperative imaging follow-up at 2 years as a predictor of long-term outcomes after endovascular aneurysm repair. J Vasc Surg. 2021. PMID: 34174376. doi:10.1016/j.jvs.2021.05.044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。